Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. [electronic resource]
Producer: 20130930Description: e60047 p. digitalISSN:- 1932-6203
- Amphotericin B -- therapeutic use
- Animals
- Antifungal Agents -- therapeutic use
- Caenorhabditis elegans -- microbiology
- Candida -- drug effects
- Candidiasis -- drug therapy
- Fluconazole -- therapeutic use
- Lepidoptera -- microbiology
- Pyrimidines -- therapeutic use
- Triazoles -- therapeutic use
- Voriconazole
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.